ISAAC Phase III Study Group Worldwide trends in the prevalence of asthma symptoms: Phase III of the International Study of Asthma and Allergies in Childhood (ISAAC)

Centre for Public Health Research, Massey University Wellington Campus, Private Box 756, Wellington, New Zealand.
Thorax (Impact Factor: 8.29). 10/2007; 62(9):758-66. DOI: 10.1136/thx.2006.070169
Source: PubMed


Phase I of the International Study of Asthma and Allergies in Childhood (ISAAC) was designed to allow worldwide comparisons of the prevalence of asthma symptoms. In phase III the phase I survey was repeated in order to assess changes over time.
The phase I survey was repeated after an interval of 5-10 years in 106 centres in 56 countries in children aged 13-14 years (n = 304,679) and in 66 centres in 37 countries in children aged 6-7 years (n = 193,404).
The mean symptom prevalence of current wheeze in the last 12 months changed slightly from 13.2% to 13.7% in the 13-14 year age group (mean increase of 0.06% per year) and from 11.1% to 11.6% in the 6-7 year age group (mean increase of 0.13% per year). There was also little change in the mean symptom prevalence of severe asthma or the symptom prevalence measured with the asthma video questionnaire. However, the time trends in asthma symptom prevalence showed different regional patterns. In Western Europe, current wheeze decreased by 0.07% per year in children aged 13-14 years but increased by 0.20% per year in children aged 6-7 years. The corresponding findings per year for the other regions in children aged 13-14 years and 6-7 years, respectively, were: Oceania (-0.39% and -0.21%); Latin America (+0.32% and +0.07%); Northern and Eastern Europe (+0.26% and +0.05%); Africa (+0.16% and +0.10%); North America (+0.12% and +0.32%); Eastern Mediterranean (-0.10% and +0.79%); Asia-Pacific (+0.07% and -0.06%); and the Indian subcontinent (+0.02% and +0.06%). There was a particularly marked reduction in current asthma symptom prevalence in English language countries (-0.51% and -0.09%). Similar patterns were observed for symptoms of severe asthma. However, the percentage of children reported to have had asthma at some time in their lives increased by 0.28% per year in the 13-14 year age group and by 0.18% per year in the 6-7 year age group.
These findings indicate that international differences in asthma symptom prevalence have reduced, particularly in the 13-14 year age group, with decreases in prevalence in English speaking countries and Western Europe and increases in prevalence in regions where prevalence was previously low. Although there was little change in the overall prevalence of current wheeze, the percentage of children reported to have had asthma increased significantly, possibly reflecting greater awareness of this condition and/or changes in diagnostic practice. The increases in asthma symptom prevalence in Africa, Latin America and parts of Asia indicate that the global burden of asthma is continuing to rise, but the global prevalence differences are lessening.

Download full-text


Available from: Colin F Robertson,
1 Follower
44 Reads
  • Source
    • "Very few studies have explored the prevalence and risk factors of respiratory conditions among adolescents in the UAE or neighboring countries. Implementation of the International Study of Asthma and Atopy in Children (ISAAC) in countries neighboring the UAE, suggest that the prevalence of asthma among adolescents is between 5 to 10%, of wheeze between 6 to 11%, and below 20% for dry nocturnal cough (ISAAC, 1998; Pearce et al., 2007). "
    [Show abstract] [Hide abstract]
    ABSTRACT: This study aims to determine the prevalence of asthma, wheeze and dry nocturnal cough, and also to assess predictors of these health outcomes among adolescents from nine different geographic regions in the United Arab Emirates (UAE). Guided by the population health framework, analysis focused on responses to select items from a survey that was administered on 6,363 UAE adolescents. Frequency analyses determined the prevalence of health outcomes and explanatory variables. Bivariate analyses assessed associations between each outcome and all explanatory variables. Logistic regression models were used to identify significant predictors of asthma, wheeze, and dry nocturnal cough for each geographic region. The prevalence of asthma, wheeze, and dry nocturnal cough ranged from 7.0 to 16.9%, 9.3 to 14.8% and 30.4 to 48.2% respectively. Associations between health outcomes and explanatory variables vary across regions. Results of multivariate regression modeling identified significant predictors of the respiratory conditions, which varied across regions. The prevalence proportions of respiratory symptoms and particularly dry nocturnal cough are relatively high in the UAE. Predictors of respiratory health in the UAE differ across regions and may be closely tied to the regional physical and social environments, which are linked to individual behaviors and lifestyles.
    04/2015; 7(4):122-137. DOI:10.5897/JPHE2015.0707
  • Source
    • "Importantly , the greater the number of home environmental risk factors, the higher the risk of any AR. Our finding of family allergic history as a significant risk for AR has been reported previously [22] as has the higher risk for boys than girls [5] [8] [19] [23] [24]. Both family history and gender were adjusted for in all multivariate models. "
    [Show abstract] [Hide abstract]
    ABSTRACT: The prevalence of allergic rhinitis (AR) among children has increased markedly in Beijing during the last two decades. The purpose of this study was to estimate the prevalence of AR and to identify indoor risk factors for AR among preschool children. A cross-sectional questionnaire survey was conducted in Beijing, 2011. Parents of 5388 3-6 years old children (65% response rate) from randomly selected kindergartens in Beijing participated in this study. A Chi-square test and multiple logistic regressions were used to identify risk factors. Our survey found that the prevalences of “AR symptoms ever,” “AR symptoms current” (AR symptoms in the last 12 months) and “doctor-diagnosed AR” are 49.5%, 45.6% and 7.8%, respectively. Confounding factors for “AR symptoms” and/or “doctor-diagnosed AR” are gender, age, family allergic history, breastfeeding and current environmental tobacco smoke (ETS). New furniture, condensation on window pane and cockroaches are risk factors for both “AR symptoms ever” and “AR symptoms current”. Risk factors for “AR symptoms ever” include the use of humidifier and incense. A risk factor for “AR symptoms current” is mosquitoes/flies. Risk factors for “doctor-diagnosed AR” include living close to a main road or highway, visible mold spots and current pet keeping. A protective factor against doctor-diagnosed AR is opening the child’s bedroom window in winter (aOR 0.66, 95% CI 0.48, 0.92). We found that the greater the number of home environmental risk factors, the higher risk of AR. A number of home environmental factors are associated with AR among preschool children.
    Building and Environment 02/2015; 93. DOI:10.1016/j.buildenv.2015.02.010 · 3.34 Impact Factor
    • "The increase in the prevalence of allergies in developed countries can be traced back to the industrial revolution in the nineteenth century (Emanuel, 1988). This trend is now spreading outside Western Europe and North America, to rapidly developing countries in Latin America, Africa, and Asia (Pearce et al., 2007). The hygiene hypothesis was formulated to explain this trend by decreased microbial stimulation caused by diminishing family size, improved living standards, and higher personal hygiene (Strachan, 1989). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Gnotobiology technology for the breeding of experimental mice originated in the first half of the twentieth century. Earlier studies conducted in germ-free animals revealed the importance of the microbiota in the development of the immune system, gut morphology, and metabolism. These seminal studies have been confirmed and complemented by recent work that exploits the use of modern gnotobiotic technology as well as the combination of high-throughput molecular techniques to study the composition and metabolic capacity of the intestinal microbiota. From a historical perspective, this chapter discusses the evolution of theory concerning complex host-microbiota interactions and probiotics species. It also reviews the current evidence for a role of maladaptive interactions in the development of disease within and beyond the gastrointestinal tract.
Show more